TABLE 2.
Type and Indication for TEE
| Indication | Esophageal Varices (n = 79) | No Esophageal Varices (n = 112) | P Value |
|---|---|---|---|
| Diagnostic | 43 (54.4) | 69 (61.6) | 0.37 |
| Endocarditis | 23 (29.1) | 36 (32.1) | 0.66 |
| Intracardiac thrombus (before cardioversion) | 11 (13.9) | 18 (16.1) | 0.68 |
| Cardiac valve function | 7 (8.9) | 7 (6.3) | 0.50 |
| Patent foramen ovale | 2 (2.5) | 8 (7.1) | 0.16 |
| Therapeutic, nonsurgical | 4 (5.0) | 9 (8.0) | 0.56 |
| Transcatheter aortic valve replacement | 0 (0.0) | 3 (2.7) | 0.27 |
| Cardiac valve dilatation | 1 (1.3) | 0 (0.0) | 0.41 |
| Cardiac ablation | 0 (0.0) | 1 (0.9) | 1 |
| Watchman placement | 2 (2.5) | 3 (2.7) | 0.95 |
| MitraClip placement | 1 (1.3) | 1 (0.9) | 0.80 |
| Atrial septal defect closure | 0 (0.0) | 1 (0.9) | 1 |
| Therapeutic, intra‐operative | 32 (40.5) | 34 (30.4) | 0.17 |
| Liver transplantation | 21 (26.6) | 14 (12.5) | 0.01 |
| Cardiac transplantation | 1 (1.3) | 0 (0.0) | 0.41 |
| Lung transplantation | 1 (1.3) | 0 (0.0) | 0.41 |
| Combined cardiac and liver transplantation | 0 (0.0) | 1 (0.9) | 1 |
| Coronary artery bypass graft | 4 (5.1) | 8 (7.1) | 0.56 |
| Surgical cardiac valve repair or replacement | 3 (3.8) | 9 (8.0) | 0.23 |
| Pericardiectomy | 0 (0.0) | 1 (0.9) | 1 |
| Pulmonary artery embolectomy | 1 (1.3) | 0 (0.0) | 0.41 |
| Implantable cardioverter‐defibrillator replacement | 1 (1.3) | 0 (0.0) | 0.41 |
| Impella removal | 0 (0.0) | 1 (0.9) | 1 |
Variables are reported as n (%).